{
  "ticker": "MBX",
  "company_name": "MBX",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05158335",
      "title": "Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of MBX 2109 in Healthy Adult Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy",
      "start_date": "2021-11-10",
      "completion_date": "2023-06-20",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    },
    {
      "nct_id": "NCT07029412",
      "title": "Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Postbariatric Hypoglycemia",
      "start_date": "2025-08-26",
      "completion_date": "2026-01-26",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    },
    {
      "nct_id": "NCT06036784",
      "title": "Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of MBX 1416 in Healthy Subjects",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Postbariatric Hypoglycemia",
      "start_date": "2023-09-18",
      "completion_date": "2024-12-05",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    },
    {
      "nct_id": "NCT06465108",
      "title": "Safety, Pharmacokinetics and Efficacy of MBX 2109 in Patients With Hypoparathyroidism",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Hypoparathyroidism",
      "start_date": "2024-08-08",
      "completion_date": "2025-06-04",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    },
    {
      "nct_id": "NCT06496217",
      "title": "Safety and Pharmacokinetics Study of MBX 2109 in Adult Subjects With Normal and Impaired Renal Function",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Renal Impairment",
      "start_date": "2024-06-13",
      "completion_date": "2025-09-04",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    },
    {
      "nct_id": "NCT07142707",
      "title": "A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Obesity",
      "start_date": "2025-09-03",
      "completion_date": "2026-05-30",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    },
    {
      "nct_id": "NCT06531941",
      "title": "Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Hypoparathyroidism",
      "start_date": "2024-10-31",
      "completion_date": "2027-05-27",
      "enrollment": 0,
      "sponsor": "MBX Biosciences"
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1": 4,
      "PHASE2": 3
    },
    "by_status": {
      "COMPLETED": 4,
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 3,
    "completed_trials": 4,
    "conditions": [
      "Healthy",
      "Hypoparathyroidism",
      "Obesity",
      "Postbariatric Hypoglycemia",
      "Renal Impairment"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:47:37.690296",
    "search_query": "MBX",
    "url": "https://clinicaltrials.gov/search?term=MBX"
  }
}